藥華藥(6446)摩根史丹利分析報告>> 必富未上市財經網‧未上市 ... | 全台上櫃股票資訊網
會員:金貝貝10138973發表時間:2014/7/28下午05:09:27.July21,2014.TaiwanDiscoveryPharmaEssentia(6446.OT):Engineeringthe.Next-generation ...
July 21, 2014
Taiwan Discovery
PharmaEssentia (6446.OT): Engineering the Next-generation Interferon
Improved interferon may offer dosing and side effect benefits: PharmaEssentia��s lead candidate is P1101 (pegylated proline interferon �-2b), a purer and longer-acting (biweekly) version of the previous- generation Pegasys and Pegintron. Its improvements aim to significantly lower flu-like and neuro side effects.
P1101 is in Phase 3 trial for polycythemia vera (PV):
PV is a rare disease marked by high red blood cell content. PharmaEssentia expects partner AOP to complete the European trial by 4Q14. By leveraging the European data, PharmaEssentia expects the US FDA to have an accelerated evaluation. In 2012, the FDA granted P1101 the orphan drug designation. PV is designated a rare disease in the US �V i.e., prevalence of <200,000. The...
P1101 PV一線新藥>> 必富未上市財經網‧未上市股票股價‧未 ... | 全台上櫃股票資訊網
P1101 | 全台上櫃股票資訊網
必富未上市財經網‧未上市股票股價‧未上市行情>> 討論 ... | 全台上櫃股票資訊網
督促藥華藥股東大賺錢>> 必富未上市財經網‧未上市 ... | 全台上櫃股票資訊網
藥華藥(6446) | K線-討論區 | 全台上櫃股票資訊網
藥華藥(6446)台灣新藥產業的航空母艦>> 必富未上市財經網‧未 ... | 全台上櫃股票資訊網
藥華藥(6446)摩根史丹利分析報告>> 必富未上市財經網‧未上市 ... | 全台上櫃股票資訊網
藥華醫藥>> 必富未上市財經網‧未上市股票股價‧未上市行情 ... | 全台上櫃股票資訊網
【藥華醫藥股份有限公司】股票代號:6446
公司名稱:藥華醫藥股份有限公司:藥華藥產業別:生技醫療業公司地址:台北市南港區園區街3號13樓統一編號:70557655董事長:詹青...